OCBCO
BMRN icon

Oversea-Chinese Banking Corp (OCBC)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,699
Closed -$200K – 332
2025
Q2 		$200K Buy
+3,699
New +$218K 0.01% 319
2024
Q4 		– Sell
-3,498
Closed -$246K – 373
2024
Q3 		$246K Buy
+3,498
New +$292K 0.01% 361

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s BMRN Position: Q3 2025 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2025, closing a stake of 3,699 shares — an estimated $200K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in BMRN in Q3 2024 and held it in 2 quarters. The position peaked at $246K in Q3 2024. 576 funds tracked by Wall St. Rank hold BMRN as of Q3 2025.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining BioMarin Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 3,699 BioMarin Pharmaceuticals shares in Q3 2025, an estimated $200K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in BioMarin Pharmaceuticals in Q3 2024 and held it in 2 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s BioMarin Pharmaceuticals position peaked at $246K in Q3 2024.
  • 576 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2025.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q3 2025, filed 28 Oct 2025.